Hippocfaea fruits

Ukraine
Brand name Hippocfaea fruits
Form tablets
Active substance / Dosage
hip fruits · 130 g
Prescription type over-the-counter (OTC)
ATC code
Registration number UA/14079/01/01
Manufacturer Ternofarm LLC
Hippocfaea fruits tablets

INSTRUCTION FOR MEDICAL USE OF THE MEDICINAL PRODUCT ROSE HIPS FRUITS

Composition:

Active substance: rose hips fruits;

1 package contains rose hips fruits (Rosae fructus) 130 g.

Pharmaceutical form. Fruits.

Main physico-chemical properties: false fruit formed by fleshy, hollow, enlarged receptacle with remnants of reduced sepals of pale pink or orange-red color; the outer surface is convex, shiny and wrinkled, the inner surface is lighter, densely lined with bristly hairs.

Pharmacotherapeutic group. Agents affecting the digestive system and metabolic processes. ATC code A16A X.

Pharmacological Properties.

Pharmacodynamics. Biologically active substances of rosehip fruits exert anti-atherosclerotic and anti-inflammatory effects; they activate enzymatic systems and redox processes in the body, normalize carbohydrate metabolism, enhance hormone synthesis and tissue regeneration, increase the body's resistance to adverse environmental factors, stimulate bile secretion, increase diuresis, and reduce capillary fragility and permeability.

Pharmacokinetics. Not studied.

Clinical characteristics.

Indications.

A general tonic agent in acute and chronic infections, dystrophy, and physical exertion; hemorrhagic diatheses; bleeding of various etiologies, anticoagulant overdose; acute and chronic liver diseases (chronic hepatitis, cholecystitis, cholangitis); kidney and bladder disorders (nephritis, nephropathies in pregnant women) – as part of complex therapy.

Contraindications.

Hypersensitivity to the biologically active substances of the drug. Thrombophlebitis and predisposition to it, circulatory insufficiency, endocarditis, decompensated diabetes mellitus, severe kidney diseases, cholelithiasis.

Interaction with other medicinal products and other forms of interactions.

Unknown.

Special precautions for use.

After using the rosehip fruit infusion, it is recommended to rinse the mouth with warm water or a weak soda solution to prevent damage to tooth enamel.

Use during pregnancy or breastfeeding.

The safety and efficacy of the medicinal product during pregnancy and breastfeeding have not been studied. Therefore, rosehip preparations should be used only after consulting a physician and only when the expected benefit for the mother outweighs the potential risk to the fetus or infant.

Ability to influence reaction speed when driving or operating machinery.

No effect.

Method of Administration and Dosage.

Place 1 tablespoon of fruits into an enameled container, pour 200 ml (1 cup) of hot boiled water, cover with a lid, and steep in a boiling water bath for 15 minutes. Allow to cool at room temperature for 45–60 minutes, then strain, squeezing the residue into the strained infusion. Adjust the volume of the infusion to 200 ml with boiled water.

Take the infusion warm, twice daily after meals:

  • Adults and children aged 14 years and older – 1/2 cup;
  • Children aged 1 to 3 years – 1 dessert spoon;
  • Children aged 3 to 7 years – 1 tablespoon;
  • Children aged 7 to 10 years – 2 tablespoons;
  • Children aged 10 to 14 years – 1/3 cup.

The duration of treatment is determined individually by a physician, considering the nature, severity, and course characteristics of the disease, stability of the achieved therapeutic effect, and the patient's tolerance to the medicinal product.

Children.

The medicinal product may be used in children aged 1 year and older.

Overdose.

Appearance or intensification of allergic reactions. Symptomatic therapy.

Side effects.

Allergic reactions may occur (including hyperemia, itching, skin swelling).

Shelf life. 2 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C.

The prepared infusion should be stored at a temperature between 8 and 15 °C for no more than 2 days.

Keep out of reach of children.

Packaging.

130 g per packet with inner pouch.

Availability. Over-the-counter.

Manufacturer/Applicant.

LLC "Ternopharm".

Manufacturer's address / Applicant's address.

4, Fabrychna St., Ternopil, 46010, Ukraine.

Tel./Fax: (0352) 521-444, www.ternopharm.com.ua